Global Vertical Category Large Model for Biomedical Market 2025 by Company, Regions, Type and Application, Forecast to 2031

August 2025 | 146 pages | ID: G5FEA082E33AEN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to our (Global Info Research) latest study, the global Vertical Category Large Model for Biomedical market size was valued at US$ 1 million in 2024 and is forecast to a readjusted size of USD 54.1 million by 2031 with a CAGR of 15.6% during review period.

Medical large-scale models refer to artificial intelligence models designed and trained specifically for the medical and health field. Its main applications include disease prediction, auxiliary diagnosis, personalized treatment, drug research and development, etc., aiming to improve the efficiency and accuracy of medical services.

This report is a detailed and comprehensive analysis for global Vertical Category Large Model for Biomedical market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Vertical Category Large Model for Biomedical market size and forecasts, in consumption value ($ Million), 2020-2031

Global Vertical Category Large Model for Biomedical market size and forecasts by region and country, in consumption value ($ Million), 2020-2031

Global Vertical Category Large Model for Biomedical market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031

Global Vertical Category Large Model for Biomedical market shares of main players, in revenue ($ Million), 2020-2025

The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Vertical Category Large Model for Biomedical
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace

This report profiles key players in the global Vertical Category Large Model for Biomedical market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include MedPaLM- Google, BioGPT-Microsoft, GatorTron-NVIDIA, ChatDoctor, Clinical QA BioGPT-John Snow Labs, BioMedLM-CRFM, Shanhai-Yunzhisheng, Jingyi Qianxun-JD Health, Yingzhi-United Imaging Healthcare, Dayi-SenseTime, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Vertical Category Large Model for Biomedical market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
  • 10 Billion Parameters
  • 100 Billion Parameters and Above
Market segment by Application
  • Personal
  • Medical Institution
  • Universities and Research Institutes
  • Others
Market segment by players, this report covers
  • MedPaLM- Google
  • BioGPT-Microsoft
  • GatorTron-NVIDIA
  • ChatDoctor
  • Clinical QA BioGPT-John Snow Labs
  • BioMedLM-CRFM
  • Shanhai-Yunzhisheng
  • Jingyi Qianxun-JD Health
  • Yingzhi-United Imaging Healthcare
  • Dayi-SenseTime
  • Bot-Baidu
  • BiomedGP-Peking University
  • MedGPT-Left Medical Technology
  • BioMedGPT, DrugFM-Tsinghua University
  • TCMLLM-Beijing Transportation University
  • Xingguang Wenxin Medical-Huabo Cloud
  • SAMI/Deepwise MetAI-Deepwise Medical
  • HealthGPT-Dingdang Health
  • APUS Zhicao 30B-Kirin Hesheng
  • SWBind-Shenwei Shuzhi
  • ShukunGPT-Shukun Technology
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Vertical Category Large Model for Biomedical product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Vertical Category Large Model for Biomedical, with revenue, gross margin, and global market share of Vertical Category Large Model for Biomedical from 2020 to 2025.

Chapter 3, the Vertical Category Large Model for Biomedical competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Vertical Category Large Model for Biomedical market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Vertical Category Large Model for Biomedical.

Chapter 13, to describe Vertical Category Large Model for Biomedical research findings and conclusion.
1 MARKET OVERVIEW

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Vertical Category Large Model for Biomedical by Type
  1.3.1 Overview: Global Vertical Category Large Model for Biomedical Market Size by Type: 2020 Versus 2024 Versus 2031
  1.3.2 Global Vertical Category Large Model for Biomedical Consumption Value Market Share by Type in 2024
  1.3.3 10 Billion Parameters
  1.3.4 100 Billion Parameters and Above
1.4 Global Vertical Category Large Model for Biomedical Market by Application
  1.4.1 Overview: Global Vertical Category Large Model for Biomedical Market Size by Application: 2020 Versus 2024 Versus 2031
  1.4.2 Personal
  1.4.3 Medical Institution
  1.4.4 Universities and Research Institutes
  1.4.5 Others
1.5 Global Vertical Category Large Model for Biomedical Market Size & Forecast
1.6 Global Vertical Category Large Model for Biomedical Market Size and Forecast by Region
  1.6.1 Global Vertical Category Large Model for Biomedical Market Size by Region: 2020 VS 2024 VS 2031
  1.6.2 Global Vertical Category Large Model for Biomedical Market Size by Region, (2020-2031)
  1.6.3 North America Vertical Category Large Model for Biomedical Market Size and Prospect (2020-2031)
  1.6.4 Europe Vertical Category Large Model for Biomedical Market Size and Prospect (2020-2031)
  1.6.5 Asia-Pacific Vertical Category Large Model for Biomedical Market Size and Prospect (2020-2031)
  1.6.6 South America Vertical Category Large Model for Biomedical Market Size and Prospect (2020-2031)
  1.6.7 Middle East & Africa Vertical Category Large Model for Biomedical Market Size and Prospect (2020-2031)

2 COMPANY PROFILES

2.1 MedPaLM- Google
  2.1.1 MedPaLM- Google Details
  2.1.2 MedPaLM- Google Major Business
  2.1.3 MedPaLM- Google Vertical Category Large Model for Biomedical Product and Solutions
  2.1.4 MedPaLM- Google Vertical Category Large Model for Biomedical Revenue, Gross Margin and Market Share (2020-2025)
  2.1.5 MedPaLM- Google Recent Developments and Future Plans
2.2 BioGPT-Microsoft
  2.2.1 BioGPT-Microsoft Details
  2.2.2 BioGPT-Microsoft Major Business
  2.2.3 BioGPT-Microsoft Vertical Category Large Model for Biomedical Product and Solutions
  2.2.4 BioGPT-Microsoft Vertical Category Large Model for Biomedical Revenue, Gross Margin and Market Share (2020-2025)
  2.2.5 BioGPT-Microsoft Recent Developments and Future Plans
2.3 GatorTron-NVIDIA
  2.3.1 GatorTron-NVIDIA Details
  2.3.2 GatorTron-NVIDIA Major Business
  2.3.3 GatorTron-NVIDIA Vertical Category Large Model for Biomedical Product and Solutions
  2.3.4 GatorTron-NVIDIA Vertical Category Large Model for Biomedical Revenue, Gross Margin and Market Share (2020-2025)
  2.3.5 GatorTron-NVIDIA Recent Developments and Future Plans
2.4 ChatDoctor
  2.4.1 ChatDoctor Details
  2.4.2 ChatDoctor Major Business
  2.4.3 ChatDoctor Vertical Category Large Model for Biomedical Product and Solutions
  2.4.4 ChatDoctor Vertical Category Large Model for Biomedical Revenue, Gross Margin and Market Share (2020-2025)
  2.4.5 ChatDoctor Recent Developments and Future Plans
2.5 Clinical QA BioGPT-John Snow Labs
  2.5.1 Clinical QA BioGPT-John Snow Labs Details
  2.5.2 Clinical QA BioGPT-John Snow Labs Major Business
  2.5.3 Clinical QA BioGPT-John Snow Labs Vertical Category Large Model for Biomedical Product and Solutions
  2.5.4 Clinical QA BioGPT-John Snow Labs Vertical Category Large Model for Biomedical Revenue, Gross Margin and Market Share (2020-2025)
  2.5.5 Clinical QA BioGPT-John Snow Labs Recent Developments and Future Plans
2.6 BioMedLM-CRFM
  2.6.1 BioMedLM-CRFM Details
  2.6.2 BioMedLM-CRFM Major Business
  2.6.3 BioMedLM-CRFM Vertical Category Large Model for Biomedical Product and Solutions
  2.6.4 BioMedLM-CRFM Vertical Category Large Model for Biomedical Revenue, Gross Margin and Market Share (2020-2025)
  2.6.5 BioMedLM-CRFM Recent Developments and Future Plans
2.7 Shanhai-Yunzhisheng
  2.7.1 Shanhai-Yunzhisheng Details
  2.7.2 Shanhai-Yunzhisheng Major Business
  2.7.3 Shanhai-Yunzhisheng Vertical Category Large Model for Biomedical Product and Solutions
  2.7.4 Shanhai-Yunzhisheng Vertical Category Large Model for Biomedical Revenue, Gross Margin and Market Share (2020-2025)
  2.7.5 Shanhai-Yunzhisheng Recent Developments and Future Plans
2.8 Jingyi Qianxun-JD Health
  2.8.1 Jingyi Qianxun-JD Health Details
  2.8.2 Jingyi Qianxun-JD Health Major Business
  2.8.3 Jingyi Qianxun-JD Health Vertical Category Large Model for Biomedical Product and Solutions
  2.8.4 Jingyi Qianxun-JD Health Vertical Category Large Model for Biomedical Revenue, Gross Margin and Market Share (2020-2025)
  2.8.5 Jingyi Qianxun-JD Health Recent Developments and Future Plans
2.9 Yingzhi-United Imaging Healthcare
  2.9.1 Yingzhi-United Imaging Healthcare Details
  2.9.2 Yingzhi-United Imaging Healthcare Major Business
  2.9.3 Yingzhi-United Imaging Healthcare Vertical Category Large Model for Biomedical Product and Solutions
  2.9.4 Yingzhi-United Imaging Healthcare Vertical Category Large Model for Biomedical Revenue, Gross Margin and Market Share (2020-2025)
  2.9.5 Yingzhi-United Imaging Healthcare Recent Developments and Future Plans
2.10 Dayi-SenseTime
  2.10.1 Dayi-SenseTime Details
  2.10.2 Dayi-SenseTime Major Business
  2.10.3 Dayi-SenseTime Vertical Category Large Model for Biomedical Product and Solutions
  2.10.4 Dayi-SenseTime Vertical Category Large Model for Biomedical Revenue, Gross Margin and Market Share (2020-2025)
  2.10.5 Dayi-SenseTime Recent Developments and Future Plans
2.11 Bot-Baidu
  2.11.1 Bot-Baidu Details
  2.11.2 Bot-Baidu Major Business
  2.11.3 Bot-Baidu Vertical Category Large Model for Biomedical Product and Solutions
  2.11.4 Bot-Baidu Vertical Category Large Model for Biomedical Revenue, Gross Margin and Market Share (2020-2025)
  2.11.5 Bot-Baidu Recent Developments and Future Plans
2.12 BiomedGP-Peking University
  2.12.1 BiomedGP-Peking University Details
  2.12.2 BiomedGP-Peking University Major Business
  2.12.3 BiomedGP-Peking University Vertical Category Large Model for Biomedical Product and Solutions
  2.12.4 BiomedGP-Peking University Vertical Category Large Model for Biomedical Revenue, Gross Margin and Market Share (2020-2025)
  2.12.5 BiomedGP-Peking University Recent Developments and Future Plans
2.13 MedGPT-Left Medical Technology
  2.13.1 MedGPT-Left Medical Technology Details
  2.13.2 MedGPT-Left Medical Technology Major Business
  2.13.3 MedGPT-Left Medical Technology Vertical Category Large Model for Biomedical Product and Solutions
  2.13.4 MedGPT-Left Medical Technology Vertical Category Large Model for Biomedical Revenue, Gross Margin and Market Share (2020-2025)
  2.13.5 MedGPT-Left Medical Technology Recent Developments and Future Plans
2.14 BioMedGPT, DrugFM-Tsinghua University
  2.14.1 BioMedGPT, DrugFM-Tsinghua University Details
  2.14.2 BioMedGPT, DrugFM-Tsinghua University Major Business
  2.14.3 BioMedGPT, DrugFM-Tsinghua University Vertical Category Large Model for Biomedical Product and Solutions
  2.14.4 BioMedGPT, DrugFM-Tsinghua University Vertical Category Large Model for Biomedical Revenue, Gross Margin and Market Share (2020-2025)
  2.14.5 BioMedGPT, DrugFM-Tsinghua University Recent Developments and Future Plans
2.15 TCMLLM-Beijing Transportation University
  2.15.1 TCMLLM-Beijing Transportation University Details
  2.15.2 TCMLLM-Beijing Transportation University Major Business
  2.15.3 TCMLLM-Beijing Transportation University Vertical Category Large Model for Biomedical Product and Solutions
  2.15.4 TCMLLM-Beijing Transportation University Vertical Category Large Model for Biomedical Revenue, Gross Margin and Market Share (2020-2025)
  2.15.5 TCMLLM-Beijing Transportation University Recent Developments and Future Plans
2.16 Xingguang Wenxin Medical-Huabo Cloud
  2.16.1 Xingguang Wenxin Medical-Huabo Cloud Details
  2.16.2 Xingguang Wenxin Medical-Huabo Cloud Major Business
  2.16.3 Xingguang Wenxin Medical-Huabo Cloud Vertical Category Large Model for Biomedical Product and Solutions
  2.16.4 Xingguang Wenxin Medical-Huabo Cloud Vertical Category Large Model for Biomedical Revenue, Gross Margin and Market Share (2020-2025)
  2.16.5 Xingguang Wenxin Medical-Huabo Cloud Recent Developments and Future Plans
2.17 SAMI/Deepwise MetAI-Deepwise Medical
  2.17.1 SAMI/Deepwise MetAI-Deepwise Medical Details
  2.17.2 SAMI/Deepwise MetAI-Deepwise Medical Major Business
  2.17.3 SAMI/Deepwise MetAI-Deepwise Medical Vertical Category Large Model for Biomedical Product and Solutions
  2.17.4 SAMI/Deepwise MetAI-Deepwise Medical Vertical Category Large Model for Biomedical Revenue, Gross Margin and Market Share (2020-2025)
  2.17.5 SAMI/Deepwise MetAI-Deepwise Medical Recent Developments and Future Plans
2.18 HealthGPT-Dingdang Health
  2.18.1 HealthGPT-Dingdang Health Details
  2.18.2 HealthGPT-Dingdang Health Major Business
  2.18.3 HealthGPT-Dingdang Health Vertical Category Large Model for Biomedical Product and Solutions
  2.18.4 HealthGPT-Dingdang Health Vertical Category Large Model for Biomedical Revenue, Gross Margin and Market Share (2020-2025)
  2.18.5 HealthGPT-Dingdang Health Recent Developments and Future Plans
2.19 APUS Zhicao 30B-Kirin Hesheng
  2.19.1 APUS Zhicao 30B-Kirin Hesheng Details
  2.19.2 APUS Zhicao 30B-Kirin Hesheng Major Business
  2.19.3 APUS Zhicao 30B-Kirin Hesheng Vertical Category Large Model for Biomedical Product and Solutions
  2.19.4 APUS Zhicao 30B-Kirin Hesheng Vertical Category Large Model for Biomedical Revenue, Gross Margin and Market Share (2020-2025)
  2.19.5 APUS Zhicao 30B-Kirin Hesheng Recent Developments and Future Plans
2.20 SWBind-Shenwei Shuzhi
  2.20.1 SWBind-Shenwei Shuzhi Details
  2.20.2 SWBind-Shenwei Shuzhi Major Business
  2.20.3 SWBind-Shenwei Shuzhi Vertical Category Large Model for Biomedical Product and Solutions
  2.20.4 SWBind-Shenwei Shuzhi Vertical Category Large Model for Biomedical Revenue, Gross Margin and Market Share (2020-2025)
  2.20.5 SWBind-Shenwei Shuzhi Recent Developments and Future Plans
2.21 ShukunGPT-Shukun Technology
  2.21.1 ShukunGPT-Shukun Technology Details
  2.21.2 ShukunGPT-Shukun Technology Major Business
  2.21.3 ShukunGPT-Shukun Technology Vertical Category Large Model for Biomedical Product and Solutions
  2.21.4 ShukunGPT-Shukun Technology Vertical Category Large Model for Biomedical Revenue, Gross Margin and Market Share (2020-2025)
  2.21.5 ShukunGPT-Shukun Technology Recent Developments and Future Plans

3 MARKET COMPETITION, BY PLAYERS

3.1 Global Vertical Category Large Model for Biomedical Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
  3.2.1 Market Share of Vertical Category Large Model for Biomedical by Company Revenue
  3.2.2 Top 3 Vertical Category Large Model for Biomedical Players Market Share in 2024
  3.2.3 Top 6 Vertical Category Large Model for Biomedical Players Market Share in 2024
3.3 Vertical Category Large Model for Biomedical Market: Overall Company Footprint Analysis
  3.3.1 Vertical Category Large Model for Biomedical Market: Region Footprint
  3.3.2 Vertical Category Large Model for Biomedical Market: Company Product Type Footprint
  3.3.3 Vertical Category Large Model for Biomedical Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 MARKET SIZE SEGMENT BY TYPE

4.1 Global Vertical Category Large Model for Biomedical Consumption Value and Market Share by Type (2020-2025)
4.2 Global Vertical Category Large Model for Biomedical Market Forecast by Type (2026-2031)

5 MARKET SIZE SEGMENT BY APPLICATION

5.1 Global Vertical Category Large Model for Biomedical Consumption Value Market Share by Application (2020-2025)
5.2 Global Vertical Category Large Model for Biomedical Market Forecast by Application (2026-2031)

6 NORTH AMERICA

6.1 North America Vertical Category Large Model for Biomedical Consumption Value by Type (2020-2031)
6.2 North America Vertical Category Large Model for Biomedical Market Size by Application (2020-2031)
6.3 North America Vertical Category Large Model for Biomedical Market Size by Country
  6.3.1 North America Vertical Category Large Model for Biomedical Consumption Value by Country (2020-2031)
  6.3.2 United States Vertical Category Large Model for Biomedical Market Size and Forecast (2020-2031)
  6.3.3 Canada Vertical Category Large Model for Biomedical Market Size and Forecast (2020-2031)
  6.3.4 Mexico Vertical Category Large Model for Biomedical Market Size and Forecast (2020-2031)

7 EUROPE

7.1 Europe Vertical Category Large Model for Biomedical Consumption Value by Type (2020-2031)
7.2 Europe Vertical Category Large Model for Biomedical Consumption Value by Application (2020-2031)
7.3 Europe Vertical Category Large Model for Biomedical Market Size by Country
  7.3.1 Europe Vertical Category Large Model for Biomedical Consumption Value by Country (2020-2031)
  7.3.2 Germany Vertical Category Large Model for Biomedical Market Size and Forecast (2020-2031)
  7.3.3 France Vertical Category Large Model for Biomedical Market Size and Forecast (2020-2031)
  7.3.4 United Kingdom Vertical Category Large Model for Biomedical Market Size and Forecast (2020-2031)
  7.3.5 Russia Vertical Category Large Model for Biomedical Market Size and Forecast (2020-2031)
  7.3.6 Italy Vertical Category Large Model for Biomedical Market Size and Forecast (2020-2031)

8 ASIA-PACIFIC

8.1 Asia-Pacific Vertical Category Large Model for Biomedical Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Vertical Category Large Model for Biomedical Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Vertical Category Large Model for Biomedical Market Size by Region
  8.3.1 Asia-Pacific Vertical Category Large Model for Biomedical Consumption Value by Region (2020-2031)
  8.3.2 China Vertical Category Large Model for Biomedical Market Size and Forecast (2020-2031)
  8.3.3 Japan Vertical Category Large Model for Biomedical Market Size and Forecast (2020-2031)
  8.3.4 South Korea Vertical Category Large Model for Biomedical Market Size and Forecast (2020-2031)
  8.3.5 India Vertical Category Large Model for Biomedical Market Size and Forecast (2020-2031)
  8.3.6 Southeast Asia Vertical Category Large Model for Biomedical Market Size and Forecast (2020-2031)
  8.3.7 Australia Vertical Category Large Model for Biomedical Market Size and Forecast (2020-2031)

9 SOUTH AMERICA

9.1 South America Vertical Category Large Model for Biomedical Consumption Value by Type (2020-2031)
9.2 South America Vertical Category Large Model for Biomedical Consumption Value by Application (2020-2031)
9.3 South America Vertical Category Large Model for Biomedical Market Size by Country
  9.3.1 South America Vertical Category Large Model for Biomedical Consumption Value by Country (2020-2031)
  9.3.2 Brazil Vertical Category Large Model for Biomedical Market Size and Forecast (2020-2031)
  9.3.3 Argentina Vertical Category Large Model for Biomedical Market Size and Forecast (2020-2031)

10 MIDDLE EAST & AFRICA

10.1 Middle East & Africa Vertical Category Large Model for Biomedical Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Vertical Category Large Model for Biomedical Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Vertical Category Large Model for Biomedical Market Size by Country
  10.3.1 Middle East & Africa Vertical Category Large Model for Biomedical Consumption Value by Country (2020-2031)
  10.3.2 Turkey Vertical Category Large Model for Biomedical Market Size and Forecast (2020-2031)
  10.3.3 Saudi Arabia Vertical Category Large Model for Biomedical Market Size and Forecast (2020-2031)
  10.3.4 UAE Vertical Category Large Model for Biomedical Market Size and Forecast (2020-2031)

11 MARKET DYNAMICS

11.1 Vertical Category Large Model for Biomedical Market Drivers
11.2 Vertical Category Large Model for Biomedical Market Restraints
11.3 Vertical Category Large Model for Biomedical Trends Analysis
11.4 Porters Five Forces Analysis
  11.4.1 Threat of New Entrants
  11.4.2 Bargaining Power of Suppliers
  11.4.3 Bargaining Power of Buyers
  11.4.4 Threat of Substitutes
  11.4.5 Competitive Rivalry

12 INDUSTRY CHAIN ANALYSIS

12.1 Vertical Category Large Model for Biomedical Industry Chain
12.2 Vertical Category Large Model for Biomedical Upstream Analysis
12.3 Vertical Category Large Model for Biomedical Midstream Analysis
12.4 Vertical Category Large Model for Biomedical Downstream Analysis

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES

Table 1. Global Vertical Category Large Model for Biomedical Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Vertical Category Large Model for Biomedical Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Vertical Category Large Model for Biomedical Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Vertical Category Large Model for Biomedical Consumption Value by Region (2026-2031) & (USD Million)
Table 5. MedPaLM- Google Company Information, Head Office, and Major Competitors
Table 6. MedPaLM- Google Major Business
Table 7. MedPaLM- Google Vertical Category Large Model for Biomedical Product and Solutions
Table 8. MedPaLM- Google Vertical Category Large Model for Biomedical Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. MedPaLM- Google Recent Developments and Future Plans
Table 10. BioGPT-Microsoft Company Information, Head Office, and Major Competitors
Table 11. BioGPT-Microsoft Major Business
Table 12. BioGPT-Microsoft Vertical Category Large Model for Biomedical Product and Solutions
Table 13. BioGPT-Microsoft Vertical Category Large Model for Biomedical Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. BioGPT-Microsoft Recent Developments and Future Plans
Table 15. GatorTron-NVIDIA Company Information, Head Office, and Major Competitors
Table 16. GatorTron-NVIDIA Major Business
Table 17. GatorTron-NVIDIA Vertical Category Large Model for Biomedical Product and Solutions
Table 18. GatorTron-NVIDIA Vertical Category Large Model for Biomedical Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. ChatDoctor Company Information, Head Office, and Major Competitors
Table 20. ChatDoctor Major Business
Table 21. ChatDoctor Vertical Category Large Model for Biomedical Product and Solutions
Table 22. ChatDoctor Vertical Category Large Model for Biomedical Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. ChatDoctor Recent Developments and Future Plans
Table 24. Clinical QA BioGPT-John Snow Labs Company Information, Head Office, and Major Competitors
Table 25. Clinical QA BioGPT-John Snow Labs Major Business
Table 26. Clinical QA BioGPT-John Snow Labs Vertical Category Large Model for Biomedical Product and Solutions
Table 27. Clinical QA BioGPT-John Snow Labs Vertical Category Large Model for Biomedical Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Clinical QA BioGPT-John Snow Labs Recent Developments and Future Plans
Table 29. BioMedLM-CRFM Company Information, Head Office, and Major Competitors
Table 30. BioMedLM-CRFM Major Business
Table 31. BioMedLM-CRFM Vertical Category Large Model for Biomedical Product and Solutions
Table 32. BioMedLM-CRFM Vertical Category Large Model for Biomedical Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. BioMedLM-CRFM Recent Developments and Future Plans
Table 34. Shanhai-Yunzhisheng Company Information, Head Office, and Major Competitors
Table 35. Shanhai-Yunzhisheng Major Business
Table 36. Shanhai-Yunzhisheng Vertical Category Large Model for Biomedical Product and Solutions
Table 37. Shanhai-Yunzhisheng Vertical Category Large Model for Biomedical Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Shanhai-Yunzhisheng Recent Developments and Future Plans
Table 39. Jingyi Qianxun-JD Health Company Information, Head Office, and Major Competitors
Table 40. Jingyi Qianxun-JD Health Major Business
Table 41. Jingyi Qianxun-JD Health Vertical Category Large Model for Biomedical Product and Solutions
Table 42. Jingyi Qianxun-JD Health Vertical Category Large Model for Biomedical Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. Jingyi Qianxun-JD Health Recent Developments and Future Plans
Table 44. Yingzhi-United Imaging Healthcare Company Information, Head Office, and Major Competitors
Table 45. Yingzhi-United Imaging Healthcare Major Business
Table 46. Yingzhi-United Imaging Healthcare Vertical Category Large Model for Biomedical Product and Solutions
Table 47. Yingzhi-United Imaging Healthcare Vertical Category Large Model for Biomedical Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. Yingzhi-United Imaging Healthcare Recent Developments and Future Plans
Table 49. Dayi-SenseTime Company Information, Head Office, and Major Competitors
Table 50. Dayi-SenseTime Major Business
Table 51. Dayi-SenseTime Vertical Category Large Model for Biomedical Product and Solutions
Table 52. Dayi-SenseTime Vertical Category Large Model for Biomedical Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. Dayi-SenseTime Recent Developments and Future Plans
Table 54. Bot-Baidu Company Information, Head Office, and Major Competitors
Table 55. Bot-Baidu Major Business
Table 56. Bot-Baidu Vertical Category Large Model for Biomedical Product and Solutions
Table 57. Bot-Baidu Vertical Category Large Model for Biomedical Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. Bot-Baidu Recent Developments and Future Plans
Table 59. BiomedGP-Peking University Company Information, Head Office, and Major Competitors
Table 60. BiomedGP-Peking University Major Business
Table 61. BiomedGP-Peking University Vertical Category Large Model for Biomedical Product and Solutions
Table 62. BiomedGP-Peking University Vertical Category Large Model for Biomedical Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63. BiomedGP-Peking University Recent Developments and Future Plans
Table 64. MedGPT-Left Medical Technology Company Information, Head Office, and Major Competitors
Table 65. MedGPT-Left Medical Technology Major Business
Table 66. MedGPT-Left Medical Technology Vertical Category Large Model for Biomedical Product and Solutions
Table 67. MedGPT-Left Medical Technology Vertical Category Large Model for Biomedical Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 68. MedGPT-Left Medical Technology Recent Developments and Future Plans
Table 69. BioMedGPT, DrugFM-Tsinghua University Company Information, Head Office, and Major Competitors
Table 70. BioMedGPT, DrugFM-Tsinghua University Major Business
Table 71. BioMedGPT, DrugFM-Tsinghua University Vertical Category Large Model for Biomedical Product and Solutions
Table 72. BioMedGPT, DrugFM-Tsinghua University Vertical Category Large Model for Biomedical Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 73. BioMedGPT, DrugFM-Tsinghua University Recent Developments and Future Plans
Table 74. TCMLLM-Beijing Transportation University Company Information, Head Office, and Major Competitors
Table 75. TCMLLM-Beijing Transportation University Major Business
Table 76. TCMLLM-Beijing Transportation University Vertical Category Large Model for Biomedical Product and Solutions
Table 77. TCMLLM-Beijing Transportation University Vertical Category Large Model for Biomedical Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 78. TCMLLM-Beijing Transportation University Recent Developments and Future Plans
Table 79. Xingguang Wenxin Medical-Huabo Cloud Company Information, Head Office, and Major Competitors
Table 80. Xingguang Wenxin Medical-Huabo Cloud Major Business
Table 81. Xingguang Wenxin Medical-Huabo Cloud Vertical Category Large Model for Biomedical Product and Solutions
Table 82. Xingguang Wenxin Medical-Huabo Cloud Vertical Category Large Model for Biomedical Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 83. Xingguang Wenxin Medical-Huabo Cloud Recent Developments and Future Plans
Table 84. SAMI/Deepwise MetAI-Deepwise Medical Company Information, Head Office, and Major Competitors
Table 85. SAMI/Deepwise MetAI-Deepwise Medical Major Business
Table 86. SAMI/Deepwise MetAI-Deepwise Medical Vertical Category Large Model for Biomedical Product and Solutions
Table 87. SAMI/Deepwise MetAI-Deepwise Medical Vertical Category Large Model for Biomedical Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 88. SAMI/Deepwise MetAI-Deepwise Medical Recent Developments and Future Plans
Table 89. HealthGPT-Dingdang Health Company Information, Head Office, and Major Competitors
Table 90. HealthGPT-Dingdang Health Major Business
Table 91. HealthGPT-Dingdang Health Vertical Category Large Model for Biomedical Product and Solutions
Table 92. HealthGPT-Dingdang Health Vertical Category Large Model for Biomedical Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 93. HealthGPT-Dingdang Health Recent Developments and Future Plans
Table 94. APUS Zhicao 30B-Kirin Hesheng Company Information, Head Office, and Major Competitors
Table 95. APUS Zhicao 30B-Kirin Hesheng Major Business
Table 96. APUS Zhicao 30B-Kirin Hesheng Vertical Category Large Model for Biomedical Product and Solutions
Table 97. APUS Zhicao 30B-Kirin Hesheng Vertical Category Large Model for Biomedical Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 98. APUS Zhicao 30B-Kirin Hesheng Recent Developments and Future Plans
Table 99. SWBind-Shenwei Shuzhi Company Information, Head Office, and Major Competitors
Table 100. SWBind-Shenwei Shuzhi Major Business
Table 101. SWBind-Shenwei Shuzhi Vertical Category Large Model for Biomedical Product and Solutions
Table 102. SWBind-Shenwei Shuzhi Vertical Category Large Model for Biomedical Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 103. SWBind-Shenwei Shuzhi Recent Developments and Future Plans
Table 104. ShukunGPT-Shukun Technology Company Information, Head Office, and Major Competitors
Table 105. ShukunGPT-Shukun Technology Major Business
Table 106. ShukunGPT-Shukun Technology Vertical Category Large Model for Biomedical Product and Solutions
Table 107. ShukunGPT-Shukun Technology Vertical Category Large Model for Biomedical Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 108. ShukunGPT-Shukun Technology Recent Developments and Future Plans
Table 109. Global Vertical Category Large Model for Biomedical Revenue (USD Million) by Players (2020-2025)
Table 110. Global Vertical Category Large Model for Biomedical Revenue Share by Players (2020-2025)
Table 111. Breakdown of Vertical Category Large Model for Biomedical by Company Type (Tier 1, Tier 2, and Tier 3)
Table 112. Market Position of Players in Vertical Category Large Model for Biomedical, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 113. Head Office of Key Vertical Category Large Model for Biomedical Players
Table 114. Vertical Category Large Model for Biomedical Market: Company Product Type Footprint
Table 115. Vertical Category Large Model for Biomedical Market: Company Product Application Footprint
Table 116. Vertical Category Large Model for Biomedical New Market Entrants and Barriers to Market Entry
Table 117. Vertical Category Large Model for Biomedical Mergers, Acquisition, Agreements, and Collaborations
Table 118. Global Vertical Category Large Model for Biomedical Consumption Value (USD Million) by Type (2020-2025)
Table 119. Global Vertical Category Large Model for Biomedical Consumption Value Share by Type (2020-2025)
Table 120. Global Vertical Category Large Model for Biomedical Consumption Value Forecast by Type (2026-2031)
Table 121. Global Vertical Category Large Model for Biomedical Consumption Value by Application (2020-2025)
Table 122. Global Vertical Category Large Model for Biomedical Consumption Value Forecast by Application (2026-2031)
Table 123. North America Vertical Category Large Model for Biomedical Consumption Value by Type (2020-2025) & (USD Million)
Table 124. North America Vertical Category Large Model for Biomedical Consumption Value by Type (2026-2031) & (USD Million)
Table 125. North America Vertical Category Large Model for Biomedical Consumption Value by Application (2020-2025) & (USD Million)
Table 126. North America Vertical Category Large Model for Biomedical Consumption Value by Application (2026-2031) & (USD Million)
Table 127. North America Vertical Category Large Model for Biomedical Consumption Value by Country (2020-2025) & (USD Million)
Table 128. North America Vertical Category Large Model for Biomedical Consumption Value by Country (2026-2031) & (USD Million)
Table 129. Europe Vertical Category Large Model for Biomedical Consumption Value by Type (2020-2025) & (USD Million)
Table 130. Europe Vertical Category Large Model for Biomedical Consumption Value by Type (2026-2031) & (USD Million)
Table 131. Europe Vertical Category Large Model for Biomedical Consumption Value by Application (2020-2025) & (USD Million)
Table 132. Europe Vertical Category Large Model for Biomedical Consumption Value by Application (2026-2031) & (USD Million)
Table 133. Europe Vertical Category Large Model for Biomedical Consumption Value by Country (2020-2025) & (USD Million)
Table 134. Europe Vertical Category Large Model for Biomedical Consumption Value by Country (2026-2031) & (USD Million)
Table 135. Asia-Pacific Vertical Category Large Model for Biomedical Consumption Value by Type (2020-2025) & (USD Million)
Table 136. Asia-Pacific Vertical Category Large Model for Biomedical Consumption Value by Type (2026-2031) & (USD Million)
Table 137. Asia-Pacific Vertical Category Large Model for Biomedical Consumption Value by Application (2020-2025) & (USD Million)
Table 138. Asia-Pacific Vertical Category Large Model for Biomedical Consumption Value by Application (2026-2031) & (USD Million)
Table 139. Asia-Pacific Vertical Category Large Model for Biomedical Consumption Value by Region (2020-2025) & (USD Million)
Table 140. Asia-Pacific Vertical Category Large Model for Biomedical Consumption Value by Region (2026-2031) & (USD Million)
Table 141. South America Vertical Category Large Model for Biomedical Consumption Value by Type (2020-2025) & (USD Million)
Table 142. South America Vertical Category Large Model for Biomedical Consumption Value by Type (2026-2031) & (USD Million)
Table 143. South America Vertical Category Large Model for Biomedical Consumption Value by Application (2020-2025) & (USD Million)
Table 144. South America Vertical Category Large Model for Biomedical Consumption Value by Application (2026-2031) & (USD Million)
Table 145. South America Vertical Category Large Model for Biomedical Consumption Value by Country (2020-2025) & (USD Million)
Table 146. South America Vertical Category Large Model for Biomedical Consumption Value by Country (2026-2031) & (USD Million)
Table 147. Middle East & Africa Vertical Category Large Model for Biomedical Consumption Value by Type (2020-2025) & (USD Million)
Table 148. Middle East & Africa Vertical Category Large Model for Biomedical Consumption Value by Type (2026-2031) & (USD Million)
Table 149. Middle East & Africa Vertical Category Large Model for Biomedical Consumption Value by Application (2020-2025) & (USD Million)
Table 150. Middle East & Africa Vertical Category Large Model for Biomedical Consumption Value by Application (2026-2031) & (USD Million)
Table 151. Middle East & Africa Vertical Category Large Model for Biomedical Consumption Value by Country (2020-2025) & (USD Million)
Table 152. Middle East & Africa Vertical Category Large Model for Biomedical Consumption Value by Country (2026-2031) & (USD Million)
Table 153. Global Key Players of Vertical Category Large Model for Biomedical Upstream (Raw Materials)
Table 154. Global Vertical Category Large Model for Biomedical Typical Customers

LIST OF FIGURES

Figure 1. Vertical Category Large Model for Biomedical Picture
Figure 2. Global Vertical Category Large Model for Biomedical Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Vertical Category Large Model for Biomedical Consumption Value Market Share by Type in 2024
Figure 4. 10 Billion Parameters
Figure 5. 100 Billion Parameters and Above
Figure 6. Global Vertical Category Large Model for Biomedical Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 7. Vertical Category Large Model for Biomedical Consumption Value Market Share by Application in 2024
Figure 8. Personal Picture
Figure 9. Medical Institution Picture
Figure 10. Universities and Research Institutes Picture
Figure 11. Others Picture
Figure 12. Global Vertical Category Large Model for Biomedical Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 13. Global Vertical Category Large Model for Biomedical Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 14. Global Market Vertical Category Large Model for Biomedical Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 15. Global Vertical Category Large Model for Biomedical Consumption Value Market Share by Region (2020-2031)
Figure 16. Global Vertical Category Large Model for Biomedical Consumption Value Market Share by Region in 2024
Figure 17. North America Vertical Category Large Model for Biomedical Consumption Value (2020-2031) & (USD Million)
Figure 18. Europe Vertical Category Large Model for Biomedical Consumption Value (2020-2031) & (USD Million)
Figure 19. Asia-Pacific Vertical Category Large Model for Biomedical Consumption Value (2020-2031) & (USD Million)
Figure 20. South America Vertical Category Large Model for Biomedical Consumption Value (2020-2031) & (USD Million)
Figure 21. Middle East & Africa Vertical Category Large Model for Biomedical Consumption Value (2020-2031) & (USD Million)
Figure 22. Company Three Recent Developments and Future Plans
Figure 23. Global Vertical Category Large Model for Biomedical Revenue Share by Players in 2024
Figure 24. Vertical Category Large Model for Biomedical Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 25. Market Share of Vertical Category Large Model for Biomedical by Player Revenue in 2024
Figure 26. Top 3 Vertical Category Large Model for Biomedical Players Market Share in 2024
Figure 27. Top 6 Vertical Category Large Model for Biomedical Players Market Share in 2024
Figure 28. Global Vertical Category Large Model for Biomedical Consumption Value Share by Type (2020-2025)
Figure 29. Global Vertical Category Large Model for Biomedical Market Share Forecast by Type (2026-2031)
Figure 30. Global Vertical Category Large Model for Biomedical Consumption Value Share by Application (2020-2025)
Figure 31. Global Vertical Category Large Model for Biomedical Market Share Forecast by Application (2026-2031)
Figure 32. North America Vertical Category Large Model for Biomedical Consumption Value Market Share by Type (2020-2031)
Figure 33. North America Vertical Category Large Model for Biomedical Consumption Value Market Share by Application (2020-2031)
Figure 34. North America Vertical Category Large Model for Biomedical Consumption Value Market Share by Country (2020-2031)
Figure 35. United States Vertical Category Large Model for Biomedical Consumption Value (2020-2031) & (USD Million)
Figure 36. Canada Vertical Category Large Model for Biomedical Consumption Value (2020-2031) & (USD Million)
Figure 37. Mexico Vertical Category Large Model for Biomedical Consumption Value (2020-2031) & (USD Million)
Figure 38. Europe Vertical Category Large Model for Biomedical Consumption Value Market Share by Type (2020-2031)
Figure 39. Europe Vertical Category Large Model for Biomedical Consumption Value Market Share by Application (2020-2031)
Figure 40. Europe Vertical Category Large Model for Biomedical Consumption Value Market Share by Country (2020-2031)
Figure 41. Germany Vertical Category Large Model for Biomedical Consumption Value (2020-2031) & (USD Million)
Figure 42. France Vertical Category Large Model for Biomedical Consumption Value (2020-2031) & (USD Million)
Figure 43. United Kingdom Vertical Category Large Model for Biomedical Consumption Value (2020-2031) & (USD Million)
Figure 44. Russia Vertical Category Large Model for Biomedical Consumption Value (2020-2031) & (USD Million)
Figure 45. Italy Vertical Category Large Model for Biomedical Consumption Value (2020-2031) & (USD Million)
Figure 46. Asia-Pacific Vertical Category Large Model for Biomedical Consumption Value Market Share by Type (2020-2031)
Figure 47. Asia-Pacific Vertical Category Large Model for Biomedical Consumption Value Market Share by Application (2020-2031)
Figure 48. Asia-Pacific Vertical Category Large Model for Biomedical Consumption Value Market Share by Region (2020-2031)
Figure 49. China Vertical Category Large Model for Biomedical Consumption Value (2020-2031) & (USD Million)
Figure 50. Japan Vertical Category Large Model for Biomedical Consumption Value (2020-2031) & (USD Million)
Figure 51. South Korea Vertical Category Large Model for Biomedical Consumption Value (2020-2031) & (USD Million)
Figure 52. India Vertical Category Large Model for Biomedical Consumption Value (2020-2031) & (USD Million)
Figure 53. Southeast Asia Vertical Category Large Model for Biomedical Consumption Value (2020-2031) & (USD Million)
Figure 54. Australia Vertical Category Large Model for Biomedical Consumption Value (2020-2031) & (USD Million)
Figure 55. South America Vertical Category Large Model for Biomedical Consumption Value Market Share by Type (2020-2031)
Figure 56. South America Vertical Category Large Model for Biomedical Consumption Value Market Share by Application (2020-2031)
Figure 57. South America Vertical Category Large Model for Biomedical Consumption Value Market Share by Country (2020-2031)
Figure 58. Brazil Vertical Category Large Model for Biomedical Consumption Value (2020-2031) & (USD Million)
Figure 59. Argentina Vertical Category Large Model for Biomedical Consumption Value (2020-2031) & (USD Million)
Figure 60. Middle East & Africa Vertical Category Large Model for Biomedical Consumption Value Market Share by Type (2020-2031)
Figure 61. Middle East & Africa Vertical Category Large Model for Biomedical Consumption Value Market Share by Application (2020-2031)
Figure 62. Middle East & Africa Vertical Category Large Model for Biomedical Consumption Value Market Share by Country (2020-2031)
Figure 63. Turkey Vertical Category Large Model for Biomedical Consumption Value (2020-2031) & (USD Million)
Figure 64. Saudi Arabia Vertical Category Large Model for Biomedical Consumption Value (2020-2031) & (USD Million)
Figure 65. UAE Vertical Category Large Model for Biomedical Consumption Value (2020-2031) & (USD Million)
Figure 66. Vertical Category Large Model for Biomedical Market Drivers
Figure 67. Vertical Category Large Model for Biomedical Market Restraints
Figure 68. Vertical Category Large Model for Biomedical Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Vertical Category Large Model for Biomedical Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source


More Publications